Liabilities / Assets
47th percentile
Tied with the lowest-debt nonprofits in its peer group.
990 • Fiscal year 2017 • EIN 47-5288440
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
Liabilities / Assets
47th percentile
Tied with the lowest-debt nonprofits in its peer group.
Liabilities / Revenue
47th percentile
Tied with the lowest-debt nonprofits in its peer group.
Net Margin
13th percentile
Higher net margin than 13% of similar nonprofits.
Top Officer Pay
Score unavailable
This filing does not contain officer compensation rows.
Asset Growth
100th percentile
Faster asset growth than 100% of similar nonprofits.
Revenue Growth
Score unavailable
A valid growth rate could not be computed from the available filing history.
Assets
Up$701
Up $700 (+70000%) from 2015
Net Assets
$701
No earlier filing loaded for comparison.
Liabilities
Flat$0
Flat from 2015
Revenue
Up$26,698
Up $26,698 from 2015
Expenses
Up$32,307
Up $32,307 from 2015
Net Income
Down-$5,609
Down $5,609 from 2015
This 2017 filing currently has summary financial data only. Detailed schedules, leadership, and program rows are not available for this filing yet.
To conduct effective advocacy for public policies that encourage the implementation of practices and technologies directed by pharmacists and biotechnology companies that minimize side effects and improve overall patient outcomes, and to support the needs of our members that represent the precision medicine industry.
No mirrored PDF or thumbnail assets are attached yet.
Displayed year
2017 • Form 990Summary only. Only limited summary data is available for this year.